These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35003394)

  • 1. CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis.
    Ye T; Li LL; Peng XM; Li Q
    Dis Markers; 2021; 2021():8565943. PubMed ID: 35003394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma.
    Cheng L; Han T; Chen B; Nie K; Peng W
    BMC Cancer; 2021 Jul; 21(1):794. PubMed ID: 34238250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer.
    Huang C; Cui H; Lang X; Zhao F
    J Immunol Res; 2022; 2022():9912732. PubMed ID: 35795530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
    Ye M; Wang S; Qie JB; Sun PL
    Front Oncol; 2021; 11():765484. PubMed ID: 34671565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
    Zhao S; Jiang H; Liu J; Li DY; Li B; Long QR; Zheng L; Gu H
    Dis Markers; 2022; 2022():5994800. PubMed ID: 35251374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SLC44A3-AS1 Enhancer RNA in Esophageal Cancer Prognosis.
    Kang K; Wu J; Mao Y; Kai J; Chen S; Xiong F
    J Coll Physicians Surg Pak; 2023 Sep; 33(9):964-971. PubMed ID: 37691355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP4-AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer.
    Hua T; Tian YJ; Wang RM; Zhao CF; Kong YH; Tian RQ; Wang W; Ma LX
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33870423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
    Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
    Front Immunol; 2021; 12():706936. PubMed ID: 34899682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
    Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
    J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXB-AS1 accelerates the tumorigenesis of glioblastoma via modulation of HOBX2 and HOBX3 at transcriptional and posttranscriptional levels.
    Bi Y; Mao Y; Su Z; Du J; Ye L; Xu F
    J Cell Physiol; 2021 Jan; 236(1):93-106. PubMed ID: 33459377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma.
    Zhou C; Jiang X; Liang A; Zhu R; Yang Y; Zhong L; Wan D
    Neurosci Lett; 2021 Nov; 764():136245. PubMed ID: 34530115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
    Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
    J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
    Luo W; Li X; Song Z; Zhu X; Zhao S
    Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer.
    Yang S; Zou X; Yang H; Li J; Zhang A; Zhang L; Li C; Zhu L; Ma Z
    Front Genet; 2022; 13():854211. PubMed ID: 35571043
    [No Abstract]   [Full Text] [Related]  

  • 15. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.
    Chen H; Hou G; Yang J; Chen W; Guo L; Mao Q; Ge J; Zhang X
    J Cell Mol Med; 2020 Jun; 24(11):6070-6082. PubMed ID: 32329150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEF1-AS1 is implicated in the malignant development of glioblastoma via sponging miR-543 to upregulate EN2.
    Zeng S; Zhou C; Yang DH; Xu LS; Yang HJ; Xu MH; Wang H
    Brain Res; 2020 Jun; 1736():146781. PubMed ID: 32184164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma.
    Liu J; Yin J; Wang Y; Cai L; Geng R; Du M; Zhong Z; Ni S; Huang X; Yu H; Bai J
    Biol Proced Online; 2022 Jul; 24(1):9. PubMed ID: 35836132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
    Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
    Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme.
    Tian Y; Zheng Y; Dong X
    J Cell Biochem; 2019 Jun; 120(6):9056-9062. PubMed ID: 30525219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
    Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
    Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.